Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 6.25 mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
- Products
-
- Carvedilol Tablets USP 6.25 mg
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- [100 Tablet Bottles] 90,000 bottles; [500 Tablet Bottles] 324,288 bottles
- About this recall
- Carvedilol Tablets USP 6.25 mg, a.)100-count bottle (NDC 68462-163-01), b.) 500-count bottle (NDC 68462-163-05) Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.